The involvement of serotonin receptors in suanzaorentang-induced sleep alteration

Journal of Biomedical Science

Volumn 14, Issue 6, 2007, Pages 829-840

  Yi, Pei Lu ^a   Lin, Chun Pang ^b   Tsai, Chon Haw ^c   Lin, Jaung Geng ^d   Chang, Fang Chia ^c,e  

^a JEN TEH JUNIOR COLLEGE OF MEDICINE   (Taiwan)

^b Shih Hwa Chinese Medicine Clinic   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Non rapid eye movement sleep (NREMS); Rapid eye movement sleep (REMS); Serotonin; Suanzaorentang

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 3 (4 ALLYLPIPERAZIN 1 YL) 2 QUINOXALINECARBONITRILE; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; BENZODIAZEPINE DERIVATIVE; CHINESE DRUG; HYPNOTIC SEDATIVE AGENT; KETANSERIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN 3 ANTAGONIST; SEROTONIN RECEPTOR; SUANZAORENTANG; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CHINA; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG DEPENDENCE; DRUG MEGADOSE; DRUG RECEPTOR BINDING; INSOMNIA; JUJUBE; MALE; NONHUMAN; NONREM SLEEP; PRIORITY JOURNAL; RAT; REM SLEEP; SLEEP;

ANIMALS; KETANSERIN; PIPERAZINES; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT2; SLEEP; TIME FACTORS;

EID: 35348861287     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/s11373-007-9197-8     Document Type: Article

References (50)

1. Partinen M. (1994). Epidemiology of sleep disorders, In: Kryger M.H., Roth T., Dement W.C. (Eds), Principles and Practice of Sleep Medicine. WB Saunders, Philadelphia, pp. 437-452
2. Chung K.F., Lee C.K.Y. (2002). Over-the-counter sleeping pills: a survey of use in Hong Kong and a review of their constituents. Gen. Hosp. Psychiatry 24: 430-435
3. Chen H.C., Hsieh M.T. (1985). Clinical trial of suanzaorentang in the treatment of insomnia. Clin. Therapeut. 7: 334-337
4. Chen H.C., Hsieh M.T., Shibuya T. (1986). Suanzaorentang versus diazepam: a controlled double-blind study in anxiety. Int. J. Clin. Pharmacol. Therapy Toxicol. 24: 646-650
5. Yi P.L., Tsai C.H., Chen Y.C., Chang F.C. (2007). Gamma-aminobutyric acid (GABA) receptor mediates suanzaorentang, a traditional Chinese herb remedy, induced sleep alteration. J. Biomed. Sci. 14: 285-297
6. Park J.H., Lee H.J., Koh S.M., Ban J.Y., Seong Y.H. (2004). Protection of NMDA-induced neuronal cell damage by methanol extract of Zizyphi Spinosi Semen in cultured rat cerebellar granule cells. J. Ethnopharmacol. 95: 39-45
7. Zheng H.Z., Dong A.H. and She J., (Eds) Modern Study of Traditional Chinese Medicine (in Chinese). Xue Yuan Press, Beijing, 1997
8. Kanba S., Yamada K., Mizushima H., Murata T., Asai M. (1999). Use of herbal medicine for treating psychiatric disorders in Japan. In: Kanba S., Richelson E. (Eds), Herbal Medicines for Neuropsychiatric Diseases: Current Developments and Research. Brunner/Mazel, New York, pp. 3-14
9. Yu S.J., Tseng J. (1996). Fu-ling, a Chinese herbal drug, modulates cytokine secretion by human peripheral blood monocytes. Int. J. Immunopharmacol. 18: 37-44
10. Liao S.L., Kao T.K., Chen W.Y., Lin Y.S., Chen S.Y., Raung S.L., Wu C.W., Lu H.C., Chen C.J. (2004). Tetramethylpyrazine reduces ischemic brain injury in rats. Neurosci. Lett. 372: 40-45
11. Tsukamoto S., Wakana T., Koimaru K., Yoshida T., Sato M., Ohta T. (2005). 7-Hydroxy)3-(4-hydroxybenzyl) chroman and Broussonin B: neurotrophic compounds, isolated from Anemarrhena asphodeloides BUNGE, function as proteasome inhibitors. Biol. Pharm. Bull. 28: 1798-1800
12. Tsuda T., Kubota K., Yasuda K., Nishikawa S., Sugaya A., Sugaya E. (1986). Effects of Chinese herbal medicine "kanbaku-taiso-to" on transmembrane ionic currents and its local anesthetic action. J. Ethnopharmacol. 17: 257-261
13. Liao J.F., Jan Y.M., Huang S.Y., Wang H.H., Yu L.L., Chen C.F. (1995). Evaluation with receptor binding assay on the water extracts of ten CNS-active Chinese herbal drugs. Proc. Natl. Sci. Council ROC - Part B Life Sci. 19: 151-158
14. Jouvet M. (1999). Sleep and serotonin: an unfinished story. Neuropsychopharmacology 21: 24S-27S
15. Portas C.M., Bjorvatn B., Ursin R. (2000). Serotonin and the sleep-wake cycle: special emphasis on microdialysis studies. Prog. Neurobiol. 60: 13-35
16. Jouvet M. (1968). Insomnia and decrease of cerebral 5-hydroxytryptamine after destruction of the raphe system in the cat. Adv. Pharmacol. 6(Pt B): 265-279
17. Jouvet M. (1969). Biogenic amines and the states of sleep. Science 163: 32-41
18. Pujol J.F., Buguet A., Froment J.L., Jones B., Jouvet M. (1971). The central metabolism of serotonin in the cat during insomnia. A neurophysiological and biochemical study after administration of p-chlorophenylalanine or destruction of the raphe system. Brain Res. 29: 195-212
19. Monti J.M., Jantos H. (2004). Effects of the 5-HT1A receptor ligands flesinoxan and WAY 100635 given systemically or microinjected into the laterodorsal tegmental nucleus on REM sleep in the rat. Behav. Brain Res. 151: 159-166
20. Popa D., Lena C., Fabre V., Prenat C., Gingrich J., Escourrou P., Hamon M., Adrien J. (2005). Contribution of 5-HT2 receptor subtypes to sleep-wakefulness and respiratory control, and functional adaptations in knock-out mice lacking 5-HT2A receptors. J. Neurosci. 25: 11231-11238
21. Yi P.L., Tsai C.H., Lu M.K., Liu H.J., Chen Y.C., Chang F.C. (2007). Interleukin-1β mediates sleep alteration in rats with rotenone-induced parkinsonism. Sleep 30: 413-425
22. Epstein A.M., Fitzsimons J.T., Rolls B.J. (1970). Drinking induced by injection of angiotensin into the brain of the rat. J. Physiol. 210: 457-474
23. Chang F.-C., Opp M.R. (1998). Blockade of corticotropin releasing hormone receptors reduces spontaneous waking in the rat. Am. J. Physiol. 275: R793-R802
24. 1A receptor antagonists on the secretion of corticotropin and prolactin. Neuroendocrinology 73: 322-333
25. Engleman E.A., Murphy J.M., Zhou F.C., Aprison M.H., Hingtgen J.N. (1995) Operant response suppression induced with systemic administration of 5-hydroxytryptophan is centrally mediated. Pharmacol. Biochem. Behav. 52: 525-529
26. Weinger M.B., Chen D.Y., Lin T., Lau C., Koob G.F., Smith N.T. (1995). A role for CNS alpha-2 adrenergic receptors in opiate-induced muscle rigidity in the rat. Brain Res. 669: 10-18
27. Hansen M.K., Kapas L., Fang J., Krueger J.M. (1998). Cafeteria diet-induced sleep is blocked by subdiaphragmatic vagotomy in rats. Am. J. Physiol. 274: R168-R174
28. Jenkins J.B., Omori T., Guan Z., Vgontzas A.N., Bixler E.O., Fang J. (2006). Sleep is increased in mice with obesity induced by high-fat food. Physiol. Behav. 87: 255-262
29. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., Chrousos G.P. (1997). Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J. Clin. Endocrinol. Metab. 82: 1313-1316
30. Kubota T., Fang J., Guan Z., Brown R.A., Krueger J.M. (2001). Vagotomy attenuates tumor necrosis factor-alpha induced sleep and EEG delta-activity in rats. Am. J. Physiol. Regulat. Integr. Comp. Physiol. 280: R1213-R1220
31. McGinty D.J., Harper R.M. (1976). Dorsal raphe neurons: depression of firing during sleep in cats. Brain Res. 101: 569-575
32. 2+ channel blockers on pentobarbital-induced hypnosis are influenced by serotonergic system. J. Neural Transm. 113: 1395-1402
33. Guha M., Biswas S., Poddar M.K. (1988). Possible involvement of central cholinergic-serotonergic interaction in nature sleep. Methods Find Exp. Clin. Pharmacol. 10: 243-245
34. Gao B., Duncan W.C. Jr., Wehr T.A. (1992). Fluoxetine decreases brain temperature and REM sleep in Syrian hamsters. Psychopharmacology 106: 321-329
35. 1A antagonist NAN-190 alone and in combination with citalopram. Behav. Brain Res. 75: 159-168
36. th European Congress on Sleep Research. Gustav-Fisher-Verlag, Stuttgart, pp. 346-348
37. 1A receptor agonist 8-OH-DPAT on sleep and wakefulness in the rat. J. Sleep Res. 1: 169-175
38. 1A agonist, on sleep/wakefulness cycles: probable post-synaptic action. J. Sleep Res. 2: 103-109
39. Dugovic C. (2001) Role of serotonin in sleep mechanisms. Rev. Neurol. 157: S16-S19
40. Adrien J. (1995). The serotoninergic system and sleep-wakefulness regulation. In: Kales A. (Ed), The Pharmacology of Sleep. Springer-Verlag, Berlin, pp. 91-116
41. Siegel J.M. (2004). Hypocretin (orexin): role in normal behavior and neuropathology. Annu. Rev. Psychol. 55: 125-148
42. Lee M. and Jones B.E., Discharge of identified orexin neurons across the sleep-wake cycle. Neurosci. Abstr. 841.1, 2004
43. Thakkar M.M., Ramesh V., Strecker R.E., McCarley R.W. (2001). Microdialysis perfusion of orexin-A in the basal forebrain increases wakefulness in freely behaving rats. Arch. Ital. Biol. 139: 313-328
44. Bourgin P., Huitron-Resendiz S., Spier A.D., Fabre V., Morte B., Criado J.R., Sutcliffe J.G., Henriksen S.J., de Lecea L. (2000). Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J. Neurosci. 20: 7760-7765
45. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., Richardson J.A., Williams S.C., Xiong Y., Kisanuki Y., Fitch T.E., Nakazato M., Hammer R.E., Saper C.B., Yanagisawa M. (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98: 437-451
46. Thannickal T.C., Moore R.Y., Nienhuis R., Ramanathan L., Gulyani S., Aldrich M., Cornford M., Siegel J.M. (2000). Reduced number of hypocretin neurons in human narcolepsy. Neuron 27: 469-474
47. Leander P., Vrang N., Moller M. (1998) Neuronal projections from the mesencephalic raphe nuclear complex to the suprachiasmatic nucleus and the deep pineal gland of the golden hamster (Mesocricetus auratus). J. Comp. Neurol. 399: 73-93
48. 1A receptor. J. Neurosci. 24: 7159-7166
49. Imeri L., Mancia M., Opp M.R. (1999). Blockade of 5-hydroxytryptamine (serotonin)-2 receptors alters interleukin-1-induced changes in rat sleep. Neuroscience 92: 745-749
50. Ponzoni A., Monti J.M., Jantos H. (1993). The effects of selective activation of the 5-HT3 receptor with m-chlorophenylbiguanide on sleep and wakefulness in the rat. Eur. J. Neurosci. 249: 259-264